Browse by author
Lookup NU author(s): Dr Louise Robinson
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).
Health-care stakeholders increasingly recognize that the scientific and economic challenges associated with Alzheimer's disease (AD) are simply too great for individual stakeholder groups to address solely from within their own silos. In the necessary spirit of collaboration, we present in this perspective a set of multicountry multistakeholder recommendations to improve the organization of existing AD and dementia care and the development of new treatments. In brief, the five recommendations are (1) health-care systems must make choices regarding the patient populations to be diagnosed and treated, (2) health-care systems should use an evidence-based standard of care, (3) increased collaboration between public and private institutions is needed to enhance research, (4) reimbursement end points need to be agreed on and validated, and (5) innovative business models should be used to spur the introduction of new medicines. (C) 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Author(s): Bradley P, Akehurst R, Ballard C, Banerjee S, Blennow K, Bremner J, Broich K, Cummings J, Dening K, Dubois B, Klipper W, Leibman C, Mantua V, Molinuevo JL, Morgan S, Muscolo LAA, Nicolas F, Pani L, Robinson L, Siviero P, van Dam J, Van Emelen J, Wimo A, Wortmann M, Goh L
Publication type: Article
Publication status: Published
Journal: Alzheimer's & Dementia
Year: 2015
Volume: 11
Issue: 4
Pages: 455-461
Print publication date: 01/04/2015
Online publication date: 21/04/2014
Date deposited: 25/08/2015
ISSN (print): 1552-5260
ISSN (electronic): 1552-5279
Publisher: Elsevier
URL: http://dx.doi.org/10.1016/j.jalz.2014.01.007
DOI: 10.1016/j.jalz.2014.01.007
Altmetrics provided by Altmetric
